Bright Uro, an Irvine, CA-based medical device company, raised $23M in Series A funding.
The round was led by Laborie Medical Technologies.
The company intends to use the funds to achieve FDA 510(k) clearance of the Glean™ Urodynamics System (Glean) and launch the product in the U.S. in 2024.
Led by Founder and CEO Derek Herrera, Bright Uro provides the investigational Glean™ Urodynamics System, which is designed to enable wireless, catheter-free urodynamics monitoring, with the goal of improving patient comfort and clinical outcomes.
The company also announced the appointment of Suranjan Roychowdhury, Ph.D. as Chief Product Development Officer and Casey Kanel as Chief Commercial Officer.
Commenting on the news, Derek Herrera said: “I am so proud of our team for achieving this incredible milestone! In just 15 months since securing an exclusive IP license from the Cleveland Clinic, we have built, tested, and manufactured not one device, but a highly complex system, including single-use disposable sensors, male and female insertion tools, a reusable uroflowmeter, and multiple software apps. At Bright Uro, our people are our most important asset. Casey and Suranjan are the right leaders joining at the perfect time to have an exponential impact as we continue on the path to bring Glean to market.”
FinSMEs
30/11/2023